本页面由Tiger Trade Technology Pte. Ltd.提供服务

Mirum Pharmaceuticals, Inc.

81.58
-4.4850-5.21%
成交量:37.92万
成交额:3,136.50万
市值:52.97亿
市盈率:-5.79
高:87.00
开:86.06
低:81.02
收:86.06
52周最高:130.00
52周最低:63.23
股本:6,493.22万
流通股本:5,641.51万
量比:0.47
换手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):-14.0800
每股收益(LYR):-0.4700
净资产收益率:-702.97%
总资产收益率:-6.79%
市净率:-508.24
市盈率(LYR):-173.56

数据加载中...

2025/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/03/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities